Erasca Raises $64M For Oncology Drug Development Using AI
socalTECH
MARCH 5, 2019
San Diego-based Erasca , a company which is using artificial intelligence to drive the discovery and development of new oncology drugs to help cure cancer, has raised $64M in a Series A funding, the company said this morning. The funding--which included both its Series A and an extension--came from ARCH Venture Partners, Andreessen Horowitz, Reneo Capital, and other private investors.
Let's personalize your content